3D cell culture has become essential in biomedical research, but many labs struggle with scalability and reproducibility. RASTRUM™ Allegro, the latest platform from Inventia Life Science, solves these challenges with automated, high-throughput bioprinting that enhances efficiency and affordability for lab managers and researchers alike.
Streamlining workflows for greater productivity
RASTRUM Allegro enables researchers to create complex 3D cell models in minutes with minimal hands-on time, helping labs increase throughput while maintaining data consistency. The platform supports drug discovery, disease modeling, and translational research, providing biologically relevant results without added complexity.
"Scientists know the value of biologically relevant models for advancing their work," said Julio Ribeiro, Founder and CEO of Inventia Life Science. "We developed RASTRUM Allegro to give researchers the ability to generate complex 3D cell models that better represent human biology. The system provides the precision and scalability needed to fuel discovery and reveal deeper biological insights."
Benefits for lab managers
- Faster experiments – Print 96-well plates in 6 minutes and 384-well plates in 9 minutes
- Increased reproducibility – Consistent data with <10% post-print CVs
- Optimized use of resources – Generates 3.5x more models from limited patient-derived samples
- Lower per-sample costs – Improves budget efficiency without sacrificing quality
With RASTRUM Allegro, lab managers can maximize productivity, reduce manual workload, and optimize research budgets, making 3D cell culture more accessible than ever before.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release click here.
